Description
4-(4,6-Diphenyl-1,3,5-triazin-2-yl)benzene-1,3-diol is an exquisite modification of benzene-1,3-diol and exhibits remarkable prowess as an inhibitory agent against select enzymes crucial in the advancement of distinct ailments. Due to its magnificent therapeutic capabilities, it has been subjected to extensive scientific scrutiny, exploring its potential in combating malignant neoplasms by specifically targeting intricate pathways implicated in neoplastic progression and dissemination.
Synonyms
2-(2,4-dihydroxyphenyl)-4,6-diphenyl-1,3,5-triazine; 4-(4,6-diphenyl-1,3,5-triazin-2-yl)-1,3-benzenediol; Appolo-116; 4,6-Diphenyl-2-(2,4-dihydroxyphenyl)-s-triazine; 1,3-Benzenediol, 4-(4,6-diphenyl-1,3,5-triazin-2-yl)-; 2-(2,4-dihydroxyphenyl)-4,6-diphenyl-s-triazine; 2-(2,4-dihydroxyphenyl)-4,6-bis-phenyl-s-triazine; 2-(2,4-dihydroxyphenyl)4,6-bis-phenyl-s-triazine; 4-(4,6-Diphenyl-1,3,5-triazine-2-yl)resorcinol; (4Z)-4-(4,6-Diphenyl-1,3,5-triazin-2(1H)-ylidene)-3-hydroxycyclohexa-2,5-dien-1-one
IUPAC Name
4-(4,6-diphenyl-1,3,5-triazin-2-yl)benzene-1,3-diol
